EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Initial clinical experience with a dual chamber rate responsive implantable cardioverter defibrillator






Pacing and Clinical Electrophysiology 23(11 Pt 2): 1986-1988

Initial clinical experience with a dual chamber rate responsive implantable cardioverter defibrillator

The present study reports the first clinical experience with the Photon DR dual chamber rate responsive ICD. Fifty-seven patients (mean age 67.6 +/- 10 years) with a mean LVEF of 0.332 in NYHA Class I (30%), II (51%), or III (19%) met the implant criteria. Tachyarrhythmia diagnoses included VF (21%), VT (49%), or VT/VF (30%). Additional bradycardia pacing diagnoses included AV block (18%), sinus node dysfunction (5%), and sinus bradycardia (11%). All patients were followed on a long-term basis. A device-based direct current fibrillator (DC fibber) successfully induced VF in 96.2% of 243 attempted inductions. Detection times (2.86 +/- 0.47 s) and redetection times (1.29 +/- 0.32 s) compared favorably with historic controls using a morphology detection (MD) clinical data. Defibrillation energy and voltage thresholds were 10.4 +/- 5.5 J (range 3-28) and 421 V +/- 108 (range 230-696), respectively. Ninety-two clinical arrhythmias were recorded. Using a nominal nonindividualized algorithm, the sensitivity for VT detection was 100% and specificity for SVT rejection 81%. There were six patient deaths (2 nonsudden arrhythmic, 2 cardiac, 2 other). In conclusion, early clinical experience with the Photon DR ICD supports its safety, efficacy, and ability to provide advanced dual chamber ICD features.


Accession: 046415549

PMID: 11139973



Related references

Tavergne, T.T.; Ritter, P.P.; Nitzsche, R.R.; Saoudi, N.N.; Kacet, S.S.; Ollitrault, J.J.; Daubert, J.C.aude J.C.; Lacroix, D.D.; Poty, H.H., 1996: Initial clinical experience with the first dual-chamber implantable cardioverter defibrillator. Circulation 94(8 SUPPL ): I562

Auricchio, A.; Klein, H.; Kuehl, M., 1998: Initial experience with an implantable cardioverter defibrillator providing dual chamber rate adaptive pacing and sensing. Journal of the American College of Cardiology 31(2 SUPPL A): 294A, Feb

Takahashi, T.; Cannom, D.S.; Abdullah, E.; Lerman, R.D.; Park, Y.; Bishara, M.; Girsky, M.; Bhandari, A.K., 2000: Dual-Chamber Implantable Cardioverter Defibrillator vs Single-Chamber Implantable Cardioverter Defibrillator High incidence of device and lead related complications in Dual-Chamber Implantable Cardioverter Defibrillator. Journal of the American College of Cardiology 35(2 suppl A): 127A, Feb

Kuehlkamp, V.R.; Volosin, K.J.; Huegl, B.J.; Stafford, W.; Cameron, D.A.; Larsen, J.S., 1998: Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator. Circulation 98(17 SUPPL ): I191, Oct 27

Schoels, W.; Swerdlow, C.D.; Jung, W.; Stein, K.M.; Seidl, K.; Haffajee, C.J., 2001: Worldwide clinical experience with a new dual-chamber implantable cardioverter defibrillator system. Introduction: Management of atrial tachyarrhythmias represents a significant challenge in patients with implantable cardioverter defibrillators (ICDs). Drug therapy of these arrhythmias is limited by moderate efficacy, ventricular proarrhythmia, a...

Gold, M.R.; Sulke, N.; Schwartzman, D.S.; Mehra, R.; Euler, D.E., 2002: Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. This study evaluated the safety and efficacy of a new dual-chamber implantable cardioverter defibrillator (ICD) to detect and treat atrial tachyarrhythmias in patients with drug-refractory atrial fibrillation (AF) and no indication for a ventricul...

Gold, M.R.; Sulke, N.; Schwartzman, D.S.; Mehra, R.; Euler, D.E., 2001: Clinical experience with a dual-chamber implantable cardioverter defibrillator to treat atrial tachyarrhythmias. Introduction: This study evaluated the safety and efficacy of a new dual-chamber implantable cardioverter defibrillator (ICD) to detect and treat atrial tachyarrhythmias in patients with drug-refractory atrial fibrillation (AF) and no indication f...

Sulke, N.; Bailin, S.J.; Swerdlow, C.D., 1999: Worldwide clinical experience with a dual-chamber implantable cardioverter defibrillator in patients with atrial fibrillation and flutter. European Heart Journal 20(ABSTR SUPPL ): 114, Aug

Sticherling, C.; Schaumann, A.; Klingenheben, T.; Hohnloser, S.H., 2001: First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators. The need for physiological pacing and for improving the ability to discriminate atrial from ventricular tachyarrhythmias has prompted the development of dual chamber implantable cardioverter/defibrillators (ICDs). Fifty-two patients were implanted...

Dewland, T.A.; Pellegrini, C.N.; Wang, Y.; Marcus, G.M.; Keung, E.; Varosy, P.D., 2011: Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry. The aim of this study was to compare single- versus dual-chamber implantable cardioverter-defibrillator (ICD) implantation and complication rates in a large, real-world population. The majority of patients enrolled in ICD efficacy trials received...